Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Similares em SciELO
Compartilhar
Cirugía y cirujanos
versão On-line ISSN 2444-054Xversão impressa ISSN 0009-7411
Resumo
CHAPA-AZUELA, Óscar et al. Current status of pancreatic cancer with oligometastasis. Cir. cir. [online]. 2023, vol.91, n.2, pp.262-267. Epub 16-Maio-2023. ISSN 2444-054X. https://doi.org/10.24875/ciru.22000364.
Background.
Pancreatic cancer is the seventh leading cause of death worldwide, with ductal adenocarcinoma as the most frequent neoplasm. Half of the patients who are diagnosed have metastases at the time of diagnosis.
Objective.
A review of the treatment of resectable pancreatic adenocarcinoma with oligometastatic disease was carried out in order to present an overview of the existing evidence.
Method.
A bibliographic search was carried in PubMed/Medline, Clinical Key and Index Medicus vhith MESH terms, from the year 1993 to 2022.
Results.
Patients with liver or lung metastases due to pancreatic ductal adenocarcinoma who undergo surgery and chemotherapy have a longer survival in carefully selected patients.
Conclusions.
The evidence regarding surgery in patients with pancreatic ductal adenocarcinoma and oligometastasis is limited and further randomized controlled trials are needed for both scenarios. As well as established criteria that help the selection of patients who can receive this type of treatment.
Palavras-chave : Pancreatic adenocarcinoma; Pancreatic cancer; Liver metastases; Lung metastases; Pancreatoduodenectomy; Oligometastasis.